Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 21, Issue 2, 2010, Pages 557-567

  Alegret, Montserrat ^a   Vinyes Junqué, Georgina ^a   Boada, Mercè ^a,b   Martínez Lage, Pablo ^a   Cuberas, Gemma ^b   Espinosa, Ana ^a   Roca, Isabel ^b   Hernández, Isabel ^a   Valero, Sergi ^a,b   Rosende Roca, Maitée ^a   Mauleón, Ana ^a   Becker And, James T ^c   Tárraga, Lluís ^a  

^a Inst Catala de Neurociencies Apl   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; brain SPECT; cerebral perfusion; mild cognitive impairment; visuoperception

Indexed keywords

15 OBJECTS TEST; AGED; AGING; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; BRAIN PERFUSION; CINGULATE GYRUS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PARIETAL LOBE; PERCEPTION DISORDER; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; VISUOPERCEPTUAL DEFICIT;

EID: 77957369057     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-091069     Document Type: Article

References (60)

1. BellMc Ginty S, Lopez OL, Meltzer CC, Scanlon JM, Whyte EM,De Kosky, ST, Becker JT (2005) Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 62, 13931397.
2. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ (2007) Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease. Neurology 68, 828836.
3. Whitwell JL, Josephs KA,MurrayME,Kantarci K, Przybelski SA,Weigand SD, Vemuri P, Senjem ML, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW, Jack CR (2008) MRI correlates of neurofibrillary tangle pathology at autopsy: A voxelbased morphometry study. Neurology 71, 743749.
4. Karas G, Sluimer J, Goekoop R, van der Flier W, Rombouts SARB, Vrenken H, Scheltens P, Fox N, Barkhof F (2008) Amnestic mild cognitive impairment: Structural MR Imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol 29, 944949.
5. Desikan RS, Cabral HJ, Fischl B, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ (2009) Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease. Am J Neuroradiol 30, 532538.
6. Matsuda H, Kitayama N, Ohnishi T, Asada T, Nakano S, Sakamoto S, Imabayashi E,KatohA(2002) Longitudinal evaluation of bothmorphologic and functional changes in the same individuals with Alzheimer's disease. J NuclMed 43, 304311.
7. Hirao K, Ohnishi T, Hirata Y, Yamashita F,Mori T,Moriguchi Y,Matsuda H, Nemoto K, Imabayashi E, Yamada M, Iwamoto T,Arima K,Asada T (2005) The prediction of rapid conversion of Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 28, 10141021.
8. Wolf H, Jelic V, Gertz HJ, Nordberg A, Julin P, Wahlund LO (2003)Acritical discussion of the role of neuroimaging inmild cognitive impairment. Acta Neurol Scand Suppl 179, 5276.
9. Nobili F, De Carli F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Morbelli S, Guerra UP, Dessi B, Brugnolo A, Visser PJ (2009) SPECT predictors of cognitive decline and Alzheimer's disease inmild cognitive impairment. J Alzheimers Dis 17, 761772.
10. Wang H, Golob E, Bert A, Nie K, Chu Y, Dick MB, Mandelkern M, Su MY (2009) Alterations in regional brain volume and individual MRIGuided perfusion in normal control, stable mild cognitive impairment, and MCIAD converter. J Geriatr Psychiatry Neurol 22, 3545.
11. Nobili F, Salmaso D,Morbelli S, Girtler N, Piccardo A, Brugnolo A, Dessi B, Larsson SA, Rodriguez G, Pagani M(2008a) Principal compent analysis of FDG PET in amnesticMCI. Eur J Nucl Med Imaging 35, 21912202.
12. Pearlson GD, Harris GJ, Powers RE, Barta PE, Camargo EE, Chase GA, Noga JT, Tune LE (1992) Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 49, 402408.
13. Encinas M, De Juan R, Marcos A, Gil P, Barabash A, Fernández C, De Hugarte C, Cabranes JA (2003) Regional cerebral blood flow assessed with 99mTc ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease. Eur J Nucl Med Mol Imaging 30, 14731480.
14. Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, Albert MS (1998) Preclinical prediction of Alzheimer's disease using SPECT. Neurology 50, 15631571.
15. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997)Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42, 8594.
16. Ishii K, Sasaki M, Yamaji S, Kitagaki H, Mori E (1997) Demonstration of decreased posterior cingulated perfusion in mildAlzheimer's disease bymeans ofH15 2 Opositron emission tomography. Eur J Nucl Med 24, 670673.
17. Ashford JW, Shih WJ, Coupal J, Shetty R, Schneider A, Cool C, Aleem A, Kiefer VH, Mendiondo MS, Schmitt FA (2000) Single SPECT measures of cerebral cortical perfusion reflect timeindex estimation of dementia severity in Alzheimer's disease. J Nucl Med 41, 5764.
18. Ibañez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, Rapoport SI, Schapiro MB, Horwitz B (1998) Regional glucose metabolic abnormalities are not the results of atrophy in Alzheimer's disease. Neurology 50, 15851593.
19. Nestor PJ, Cine D, Fryer TD, Clarke J, Hodges JR (2003) The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDGPET. J Neurol Neurosurg Psychiatry 74, 15211529.
20. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, Nakano S, Takasaki M (2000) Longitudinal evaluation of earlyAlzheimer's disease using brain perfusion SPECT. JNucl Med 41, 11551162.
21. Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Calvini P, Morbelli S, De Carli F, Guerra UP, Van de Pol LA, Visser PJ (2008) Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. J Neurol 255, 13441353.
22. Chételat G, Desgranges B, Eustache F (2006) [Brain profile of hypometabolism in early Alzheimer's disease: Relationships with cognitive deficits and atrophy]. Rev Neurol 162, 945951.
23. Fleischer AD, Sun S, Taylor C,Ward CP, Gamst AC, Petersen RC, Jack CR, Aisen RS, Thal LJ (2008) Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 70, 191199.
24. Nordlund A, Rolstad S, Hellström P, Sjögren M, Hansen S, Wallin A (2005) The Goteborg MCI study: Mild cognitive impairment is a heterogeneous condition. J Neurol Neurosurg Psychiatry 76, 14851490.
25. Alegret M, BoadaRovira M, Vinyes Junqu é G, Valero S, Espinosa A, Hernández I, Modinos G, RosendeRoca M, Mauleón A, Becker JT, Tárraga L (2009) Detection of visuoperceptual deficits in preclinical and mild Alzheimers disease. J Clin Exp Neuropsychol 31, 860867.
26. Johnson DK, Storandt M,Morris JC, Calvin JE (2009) Longitudinal study of the transition fromhealthy aging to Alzheimer Disease. Arch Neurol 66, 12541259.
27. Paxton JL, Peavy GM, Jenkins C, Rice VA, Heindel WC, Salmon DP (2007) Deterioration of visualperceptual organization in Alzheimer's disease. Cortex 43, 967975.
28. LezakMD,Howieson DB, LoringDW(2004) Neuropsychological Assessment (4th ed.). Oxford University Press, New York.
29. Tippett WJ, Black SE (2008) Regional cerebral blood flow correlated of visuospatial tasks in Alzheimer's disease. J Int Neuropsychol Soc 14, 10341045.
30. LernerY,Hendler T, Ben Bashat D,HarelM,Malach R (2001) A hierarchical axis of object processing stages in the human visual cortex. Cereb Cortex 11, 287297.
31. Mc Khann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM(1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDSADRDA Work Group under the auspices ofDepartment ofHealth andHuman Services Task Force on Alzheimer's Disease. Neurology 34, 939944.
32. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment. Clinical characterization and outcome. Arch Neurol 56, 303308. (Pubitemid 29120227)
33. Petersen RC, Morris JC (2005) Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 62, 11601163.
34. Folstein MF, Folstein SE, Mc Hugh PR (1975) "Mini Mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189198.
35. Blesa R, Pujol M, Aguilar M, Santacruz P, Bertran Serra I, Hernández G, Sol JM, PeñaCasanova J, NORMACODEM Group (2001) Clinical validity of the 'minimental state' for Spanish speaking communities. Neuropsychologia 39, 11501157.
36. Randolph C, Tierney MC, Mohr E, Chase TN (1998) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. J Clin Exp Neuropsychol 20, 310319.
37. Martínez de la Iglesia J, Onís Vilches MC, Dueñas Herrero R, Albert Colomer C, Aguado Taverné C, Luque Luque R (2002) Versión española del cuestionario de Yesavage abreviado (GDS) para el despistaje de depresión en mayores de 65 años: Adaptación y validación. MEDIFAM 12, 620630.
38. Pillon B, Dubois B, Bonnet AM, Esteguy M, Guimaraes J, Vigouret JM, Lhermitte F, Agid Y (1989) Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: The 15objects test. Neurology 39, 762768.
39. Leroy A, Michelet D, Mahieux F, Geni D, Defer G, Monfort JC, Degos JD, N'Guyen JP, Penschanski M, Cesaro P (1996) Neuropsychological testing of 5 patients with Parkinson's disease before and after neuron graft. Rev Neurol (Paris) 152, 158164.
40. Alegret M, Vendrell P, Junqué C, Valldeoriola F, Nobbe FA, Rumià J, Tolosa E (2000) Effects of unilateral posteroventral pallidotomy on 'onoff' cognitive fluctuations in Parkinson's disease. Neuropsychologia 38, 628633.
41. Gómez-Ansón B, Alegret M, Muñoz E, Monté GC, Alayrach E, Sánchez A, Boada M, Tolosa E (2009) Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number. Parkinsonism Relat Disord 15, 213219.
42. GómezAns ón B, Alegret M, Muñoz E, Sainz A, Monte GC, Tolosa E (2007) Decreased frontal choline and neuropsychological performance in preclinical Huntington disease. Neurology 68, 906910.
43. Genovese CR, Lazar NA, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15, 870878.
44. Maldjian JA, Laurienti PJ, Burdette JH(2004) Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 21, 450455.
45. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlasbased interrogation of fMRI data sets. Neuroimage 19, 12331239.
46. Lancaster JL, Summerln JL, Rainey L, Freitas CS, Fox PT (1997) The Talairach Daemon, a database server for Talairach Atlas Labels. Neuroimage 5, S633.
47. Lancaster JL,WoldorffMG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT (2000) Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10, 120131.
48. Golden CJ (1980) In reply to Adams "In search of Luria' s battery: A false start" J Consult Clin Psychol 48, 517521.
49. Del Ser T, Sánchez F, García de Yébenes MJ, Otero A, Zunzunegui MV, Muñoz DG (2004) Versión española del Test de los 7 Minutos. Datos normativos de una muestra poblacional de ancianos de más de 70 años. Neurología 19, 344348.
50. Chételat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC (2003) Mild cognitive impairment. Can FDGPET predict who is to rapidly convert to Alzheimer's disease? Neurology 60, 13741377.
51. Okamura N, Arai H,Maruyama M, Higuchi M,Matsui T, Tanji H, Seki T, Hirai H, Chiba H, Itoh M, Sasaki H (2002) Combined analysis of CSF tau levels and [123] Iodoamphetamine SPECT inmild cognitive impairment: Implications for a novel predictor of Alzheimer's disease. Am J Psychiatry 159, 474476.
52. Buckner RL, AndrewsHanna JR, Schacter DL (2008) The brain's default network: Anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124, 138.
53. Raichle ME, Snyder AZ (2007) A default mode of brain function: A brief history of an evolving idea. Neuroimage 37, 10831090.
54. Mishkin M, Ungerleider-LG (1982) Contribution of striate inputs to the visuospatial functions of parietopreoccipital cortex in monkeys. Behav Brain Res 6, 5777.
55. Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RSJ, Hodges JR (2000) A voxelbased morphometry study of semantic dementia: Relationship between temporal lobe atrophy and semantic memory. Ann Neurol 47, 3645.
56. Braak H, Braak E (1991) Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 82, 239259.
57. Beversdorf DQ, Ferguson JLW, Hillier A, Sharma UK, Nagaraja HN, Bornstein RA, Sharre DW (2007) Problem solving abilitity in patients with mild cognitive impairment. Cogn Behav Neurol 20, 4447.
58. Traykov L, Raoux N, Latour F, Gallo L, Hanon O, Baudic S, Bayle C, Wenisch E, Remy P, Rigaud AS (2007) Executive functions deficit in mild cognitive impairment. Cogn Behav Neurol 20, 219224.
59. Espinosa A,Alegret M,Boada M,Viñas-G,Valero S,MartínezLage P, PeñaCasanova J, Becker JT, Wilson BA, Tarraga Ll (2009) Ecological assessment of executive functions in mild cognitive impairment andmild Alzheimer's disease. J Int Neuropsychol Soc 15, 751757.
60. Matsuda H (2007) The role of neuroimaging in mild cognitive impairment. Neuropathology 27, 570577.